Avivagen Announces Presentation at the Bloom Burton & Co. Healthcare Investor Conference on May 2, 2017
26 avr. 2017 15h28 HE
|
Avivagen Inc.
OTTAWA, April 26, 2017 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (OTC Pink:CHEXF) (Avivagen or the Corporation), a company with a proven and commercially-ready, patent-protected product...
Avivagen Announces Results From Its Annual and Special Meeting of Shareholders
12 avr. 2017 09h26 HE
|
Avivagen Inc.
OTTAWA, April 12, 2017 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (OTC Pink:CHEXF) (Avivagen or the Corporation), a Corporation with a proven and commercially-ready, patent-protected product...
Avivagen Reports Positive Proof of Concept in Preventing C. Difficile Infection
10 avr. 2017 07h42 HE
|
Avivagen Inc.
OTTAWA, April 10, 2017 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (OTC Pink:CHEXF) (Avivagen or the Corporation), a company with a proven and commercially-ready, patent-protected product...